Manufacture

Gene therapies look set to revolutionize the field of medicine – and AAVs have emerged as the vector of choice.

The COVID-19 pandemic has put additional supply pressures on cold-chain products, such as those encapsulated by LNPs. How can delays be avoided?

Manufacturers have a unique opportunity to take advantage of the cost and time advantages associated with Oligo(dT) – the adoption process is simple.

How far along is the pharmaceutical industry in its journey with 3D cell culture technologies?

We speak with Richard Bourne about his work on pharmaceutical processes.

Using green light, a titanium catalyst could be a non-hazardous alternative to commonly used metal-based catalysts.

Secretome engineering eliminates unwanted proteins in CHO-based bioprocessing.

We’re moving towards a data-driven future of enhanced manufacturing. And we must lay the foundations today.

We asked medicine makers around the world to tell us how their professional and personal lives have changed during the ongoing COVID-19 crisis.

A dispersible tablet could open up treatment options for pediatric patients, according to Harmony Grages, Chief Medical Officer at ViiV Healthcare.